MOVE Share Price Performance
US$8.86
-50.64 (-85.11%)
97.0% undervalued intrinsic discount
US$300.00
Fair Value
Price US$8.86
AnalystConsensusTarget US$300.00
Fair ValueUS$300.00
Share Pricen/a
Movano Inc. Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 6 Fair Values set on narratives written by author
MOVE Community Narratives
AN
Fair Value US$300 97.0% undervalued intrinsic discount
FDA Clearance And Partnerships Will Expand Wearable Healthcare Reach
0users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
FDA Clearance And Partnerships Will Expand Wearable Healthcare Reach
Key Takeaways Successful sales and market penetration of the Evie Rings indicate future revenue growth, aided by an efficient customer acquisition strategy. Strategic alliances in the healthcare sector and innovative product development suggest strong future revenue streams and market diversification.Read more
0users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
AN
US$300
97.0% undervalued intrinsic discount
AnalystConsensusTarget Fair Value
Revenue
526.48% p.a.
Profit Margin
7.53%
Future PE
43.8x
Price in 2028
US$228.88
Trending Discussion
Recently Updated Narratives
AN
FDA Clearance And Partnerships Will Expand Wearable Healthcare Reach
Fair Value: US$300 97.0% undervalued intrinsic discount
4 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Movano Inc. Key Details
Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
- -20.42
- -270.20%
- -3,409.60%
- -174.3%
About MOVE
- Founded
- 2018
- Employees
- 32
- CEO
- WebsiteView website
Movano Inc., a technology company, engages in the development of a platform to deliver healthcare solutions at the intersection of medical and consumer devices. It offers Evie Ring, a wearable device for women that combines health and wellness metrics comprising resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, and menstrual symptom tracking, as well as activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking. The company develops System-on-a-Chip (SoC) for blood pressure or continuous glucose monitoring (CGM) systems. It sells its products through its website, retail or other distribution channels, value-added resellers (VARs), as well as partnering with OEMs. The company was formerly known as Maestro Sensors Inc. and changed its name to Movano Inc. in August 2018. Movano Inc. was incorporated in 2018 and is headquartered in Pleasanton, California.
